课题基金 / 基金详情

Resolving and understanding the genomic basis of heterogeneous complex traits and diseases

Resolving and understanding the genomic basis of heterogeneous complex traits and diseases
解决和理解异质复杂性状和疾病的基因组基础
批准号:
10406616
负责人:
Arjun Krishnan
金额:
$23.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2023-07-31

项目摘要

项目成果

Arjun Krishnan的其他基金

相似基金

相关文献

中文摘要
翻译
父母给予
英文摘要
Parent grant Resolving and understanding the genomic basis of heterogeneous complex traits and diseases. Hundreds of genomics studies have exposed major gaps in our understanding of the mechanistic relationships between genomic variation, cellular processes, tissue function, and trait variation. The goal of the parent project is to develop a suite of computational frameworks that integrate massive collections of genomic and biomedical data to make the following three advances: Direction 1: Discern and leverage mechanism-based subtypes of complex traits and diseases. Direction 2: Characterize physiology and disease along the human lifespan and across the sexes. Direction 3: Find analogous contexts in model organisms for studying human traits/diseases. As demonstrated by us and others, genome-wide molecular networks are grand unifiers of molecular data and knowledge, and serve as powerful tools to contextually understand the roles genes play in cellular pathways, tissue physiology, phenotype/disease mechanisms, and drug action. Hence, a central aspect of our parent project is to develop multiple machine learning approaches to leverage molecular networks to generate accurate, testable hypotheses about the roles genes play in defining subtypes, age/sex differences, and cross-species analogs of a range of complex disorders. As part of this work, we have developed GenePlexus github.com/krishnanlab/GenePlexus, an open source software to run and benchmark our state-of-the-art approach for combining genome-scale networks with supervised machine learning (ML) to get accurate novel predictions about various gene attributes (e.g., pathway membership or disease association; Liu*, Mancuso*, et al., 2020 Bioinformatics). Similarly, our group has committed efforts to make all our other computational methods available to the broader biomedical research community in the form of software tools for open science. We have released such software with nearly all our papers. Other recent examples include: ● PecanPy github.com/krishnanlab/PecanPy for parallelized, efficient, and accelerated node2vec. ● Expresto github.com/krishnanlab/Expresto for imputing unmeasured genes in transcriptomes. ● Txt2Onto github.com/krishnanlab/Txt2Onto for annotating –omics samples based on free-text metadata. Goal of the supplement project and current prototype GenePlexus: A cloud platform for network-based machine learning The goal of the proposed supplement is to take our software development to the next level by a building a new cloud-based GenePlexus platform to enable: i) biomedical/experimental researchers to seamlessly take advantage of network-based ML to generate interpretable genome-wide predictions, and ii) computational researchers to run network-based ML, retrieve results, and integrate with existing data analysis workflows. The project team, which includes the PI, a postdoc trained in cloud computing, and two professional software engineers – has worked together over the past six months to develop a prototype of the GenePlexus platform (in the form of a web-server mounted on Microsoft Azure; Fig. 1). Figure 1: Screenshots of the current prototype of the GenePlexus webserver that implements our original GenePlexus software github.com/krishnanlab/GenePlexus. When a user uploads a geneset, GenePlexus creates a virtual machine that trains a ML model, leveraging pre-saved data. In addition to predicting genes in the network functionally similar to the user-supplied genes, GenePlexus provides enables the user to interpret the custom-built ML model in terms of its similarity to thousands of models that were trained to predict genes associated with biological processes (from Gene Ontology) and diseases (from DisGeNET). In addition to retrieving the prediction results in multiple convenient formats, users can visualize the top predicted genes as a network graph.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism-guided drug repurposing for host-directed therapy of infectious diseases using interpretable and integrative ML
  • 批准号:
    10738676
  • 项目类别:
  • 资助金额:
    $22.17万
  • 财政年份:
    2022
  • 负责人:
    Arjun Krishnan
  • 依托单位:
Mechanism-guided drug repurposing for host-directed therapy of infectious diseases using interpretable and integrative ML
  • 批准号:
    10442808
  • 项目类别:
  • 资助金额:
    $0.07万
  • 财政年份:
    2022
  • 负责人:
    Arjun Krishnan
  • 依托单位:
Mechanism-guided drug repurposing for host-directed therapy of infectious diseases using interpretable and integrative ML
  • 批准号:
    10619589
  • 项目类别:
  • 资助金额:
    $18.18万
  • 财政年份:
    2022
  • 负责人:
    Arjun Krishnan
  • 依托单位:
Resolving and understanding the genomic basis of heterogeneous complex traits and disease
  • 批准号:
    9764395
  • 项目类别:
  • 资助金额:
    $33.61万
  • 财政年份:
    2018
  • 负责人:
    Arjun Krishnan
  • 依托单位:
海外基金